Table of Content

1 Report Overview
1.1 Vascular Endothelial Growth Factor B Definition
1.2 Market by Type
1.2.1 Global Vascular Endothelial Growth Factor B Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Aflibercept
1.2.3 Aflibercept Biosimilar
1.2.4 CSL-346
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Vascular Endothelial Growth Factor B Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Rectal Cancer
1.3.3 Retinal Vein Occlusion
1.3.4 Diabetic Nephropathy
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Vascular Endothelial Growth Factor B Sales
2.1 Global Vascular Endothelial Growth Factor B Revenue Estimates and Forecasts 2018-2034
2.2 Global Vascular Endothelial Growth Factor B Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Vascular Endothelial Growth Factor B Revenue by Region
2.3.1 Global Vascular Endothelial Growth Factor B Revenue by Region (2018-2023)
2.3.2 Global Vascular Endothelial Growth Factor B Revenue by Region (2024-2034)
2.4 Global Vascular Endothelial Growth Factor B Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Vascular Endothelial Growth Factor B Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Vascular Endothelial Growth Factor B Sales Quantity by Region
2.6.1 Global Vascular Endothelial Growth Factor B Sales Quantity by Region (2018-2023)
2.6.2 Global Vascular Endothelial Growth Factor B Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Vascular Endothelial Growth Factor B Sales Quantity by Manufacturers
3.1.1 Global Vascular Endothelial Growth Factor B Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Vascular Endothelial Growth Factor B Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Vascular Endothelial Growth Factor B Sales in 2024
3.2 Global Vascular Endothelial Growth Factor B Revenue by Manufacturers
3.2.1 Global Vascular Endothelial Growth Factor B Revenue by Manufacturers (2018-2023)
3.2.2 Global Vascular Endothelial Growth Factor B Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Vascular Endothelial Growth Factor B Revenue in 2024
3.3 Global Vascular Endothelial Growth Factor B Sales Price by Manufacturers
3.4 Global Key Players of Vascular Endothelial Growth Factor B, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Vascular Endothelial Growth Factor B Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Vascular Endothelial Growth Factor B, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Vascular Endothelial Growth Factor B, Product Offered and Application
3.8 Global Key Manufacturers of Vascular Endothelial Growth Factor B, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Vascular Endothelial Growth Factor B Sales Quantity by Type
4.1.1 Global Vascular Endothelial Growth Factor B Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Vascular Endothelial Growth Factor B Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Vascular Endothelial Growth Factor B Sales Quantity Market Share by Type (2018-2034)
4.2 Global Vascular Endothelial Growth Factor B Revenue by Type
4.2.1 Global Vascular Endothelial Growth Factor B Historical Revenue by Type (2018-2023)
4.2.2 Global Vascular Endothelial Growth Factor B Forecasted Revenue by Type (2024-2034)
4.2.3 Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2018-2034)
4.3 Global Vascular Endothelial Growth Factor B Price by Type
4.3.1 Global Vascular Endothelial Growth Factor B Price by Type (2018-2023)
4.3.2 Global Vascular Endothelial Growth Factor B Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Vascular Endothelial Growth Factor B Sales Quantity by Application
5.1.1 Global Vascular Endothelial Growth Factor B Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Vascular Endothelial Growth Factor B Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Vascular Endothelial Growth Factor B Sales Quantity Market Share by Application (2018-2034)
5.2 Global Vascular Endothelial Growth Factor B Revenue by Application
5.2.1 Global Vascular Endothelial Growth Factor B Historical Revenue by Application (2018-2023)
5.2.2 Global Vascular Endothelial Growth Factor B Forecasted Revenue by Application (2024-2034)
5.2.3 Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2018-2034)
5.3 Global Vascular Endothelial Growth Factor B Price by Application
5.3.1 Global Vascular Endothelial Growth Factor B Price by Application (2018-2023)
5.3.2 Global Vascular Endothelial Growth Factor B Price Forecast by Application (2024-2034)
6 North America
6.1 North America Vascular Endothelial Growth Factor B Sales by Company
6.1.1 North America Vascular Endothelial Growth Factor B Revenue by Company (2018-2023)
6.1.2 North America Vascular Endothelial Growth Factor B Sales Quantity by Company (2018-2023)
6.2 North America Vascular Endothelial Growth Factor B Market Size by Type
6.2.1 North America Vascular Endothelial Growth Factor B Sales Quantity by Type (2018-2034)
6.2.2 North America Vascular Endothelial Growth Factor B Revenue by Type (2018-2034)
6.3 North America Vascular Endothelial Growth Factor B Market Size by Application
6.3.1 North America Vascular Endothelial Growth Factor B Sales Quantity by Application (2018-2034)
6.3.2 North America Vascular Endothelial Growth Factor B Revenue by Application (2018-2034)
6.4 North America Vascular Endothelial Growth Factor B Market Size by Country
6.4.1 North America Vascular Endothelial Growth Factor B Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Vascular Endothelial Growth Factor B Revenue by Country (2018-2034)
6.4.3 North America Vascular Endothelial Growth Factor B Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Vascular Endothelial Growth Factor B Sales by Company
7.1.1 Europe Vascular Endothelial Growth Factor B Sales Quantity by Company (2018-2023)
7.1.2 Europe Vascular Endothelial Growth Factor B Revenue by Company (2018-2023)
7.2 Europe Vascular Endothelial Growth Factor B Market Size by Type
7.2.1 Europe Vascular Endothelial Growth Factor B Sales Quantity by Type (2018-2034)
7.2.2 Europe Vascular Endothelial Growth Factor B Revenue by Type (2018-2034)
7.3 Europe Vascular Endothelial Growth Factor B Market Size by Application
7.3.1 Europe Vascular Endothelial Growth Factor B Sales Quantity by Application (2018-2034)
7.3.2 Europe Vascular Endothelial Growth Factor B Revenue by Application (2018-2034)
7.4 Europe Vascular Endothelial Growth Factor B Market Size by Country
7.4.1 Europe Vascular Endothelial Growth Factor B Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Vascular Endothelial Growth Factor B Revenue by Country (2018-2034)
7.4.3 Europe Vascular Endothelial Growth Factor B Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Vascular Endothelial Growth Factor B Sales by Company
8.1.1 China Vascular Endothelial Growth Factor B Sales Quantity by Company (2018-2023)
8.1.2 China Vascular Endothelial Growth Factor B Revenue by Company (2018-2023)
8.2 China Vascular Endothelial Growth Factor B Market Size by Type
8.2.1 China Vascular Endothelial Growth Factor B Sales Quantity by Type (2018-2034)
8.2.2 China Vascular Endothelial Growth Factor B Revenue by Type (2018-2034)
8.3 China Vascular Endothelial Growth Factor B Market Size by Application
8.3.1 China Vascular Endothelial Growth Factor B Sales Quantity by Application (2018-2034)
8.3.2 China Vascular Endothelial Growth Factor B Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Vascular Endothelial Growth Factor B Sales by Company
9.1.1 APAC Vascular Endothelial Growth Factor B Sales Quantity by Company (2018-2023)
9.1.2 APAC Vascular Endothelial Growth Factor B Revenue by Company (2018-2023)
9.2 APAC Vascular Endothelial Growth Factor B Market Size by Type
9.2.1 APAC Vascular Endothelial Growth Factor B Sales Quantity by Type (2018-2034)
9.2.2 APAC Vascular Endothelial Growth Factor B Revenue by Type (2018-2034)
9.3 APAC Vascular Endothelial Growth Factor B Market Size by Application
9.3.1 APAC Vascular Endothelial Growth Factor B Sales Quantity by Application (2018-2034)
9.3.2 APAC Vascular Endothelial Growth Factor B Revenue by Application (2018-2034)
9.4 APAC Vascular Endothelial Growth Factor B Market Size by Region
9.4.1 APAC Vascular Endothelial Growth Factor B Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Vascular Endothelial Growth Factor B Revenue by Region (2018-2034)
9.4.3 APAC Vascular Endothelial Growth Factor B Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Sales by Company
10.1.1 Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Market Size by Type
10.2.1 Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Market Size by Application
10.3.1 Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Market Size by Country
10.4.1 Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Alteogen Inc
11.1.1 Alteogen Inc Company Information
11.1.2 Alteogen Inc Overview
11.1.3 Alteogen Inc Vascular Endothelial Growth Factor B Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Alteogen Inc Vascular Endothelial Growth Factor B Products and Services
11.1.5 Alteogen Inc Vascular Endothelial Growth Factor B SWOT Analysis
11.1.6 Alteogen Inc Recent Developments
11.2 CSL Ltd
11.2.1 CSL Ltd Company Information
11.2.2 CSL Ltd Overview
11.2.3 CSL Ltd Vascular Endothelial Growth Factor B Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 CSL Ltd Vascular Endothelial Growth Factor B Products and Services
11.2.5 CSL Ltd Vascular Endothelial Growth Factor B SWOT Analysis
11.2.6 CSL Ltd Recent Developments
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Information
11.3.2 Eli Lilly and Company Overview
11.3.3 Eli Lilly and Company Vascular Endothelial Growth Factor B Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Eli Lilly and Company Vascular Endothelial Growth Factor B Products and Services
11.3.5 Eli Lilly and Company Vascular Endothelial Growth Factor B SWOT Analysis
11.3.6 Eli Lilly and Company Recent Developments
11.4 Formycon AG
11.4.1 Formycon AG Company Information
11.4.2 Formycon AG Overview
11.4.3 Formycon AG Vascular Endothelial Growth Factor B Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Formycon AG Vascular Endothelial Growth Factor B Products and Services
11.4.5 Formycon AG Vascular Endothelial Growth Factor B SWOT Analysis
11.4.6 Formycon AG Recent Developments
11.5 Regeneron Pharmaceuticals Inc
11.5.1 Regeneron Pharmaceuticals Inc Company Information
11.5.2 Regeneron Pharmaceuticals Inc Overview
11.5.3 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Products and Services
11.5.5 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B SWOT Analysis
11.5.6 Regeneron Pharmaceuticals Inc Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Vascular Endothelial Growth Factor B Value Chain Analysis
12.2 Vascular Endothelial Growth Factor B Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vascular Endothelial Growth Factor B Production Mode & Process
12.4 Vascular Endothelial Growth Factor B Sales and Marketing
12.4.1 Vascular Endothelial Growth Factor B Sales Channels
12.4.2 Vascular Endothelial Growth Factor B Distributors
12.5 Vascular Endothelial Growth Factor B Customers
13 Market Dynamics
13.1 Vascular Endothelial Growth Factor B Industry Trends
13.2 Vascular Endothelial Growth Factor B Market Drivers
13.3 Vascular Endothelial Growth Factor B Market Challenges
13.4 Vascular Endothelial Growth Factor B Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Aflibercept
Table 3. Major Manufacturers of Aflibercept Biosimilar
Table 4. Major Manufacturers of CSL-346
Table 5. Major Manufacturers of Others
Table 6. Global Vascular Endothelial Growth Factor B Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Vascular Endothelial Growth Factor B Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Vascular Endothelial Growth Factor B Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Vascular Endothelial Growth Factor B Revenue Market Share by Region (2018-2023)
Table 10. Global Vascular Endothelial Growth Factor B Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Vascular Endothelial Growth Factor B Revenue Market Share by Region (2024-2034)
Table 12. Global Vascular Endothelial Growth Factor B Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 13. Global Vascular Endothelial Growth Factor B Sales by Region (2018-2023) & (K Pcs)
Table 14. Global Vascular Endothelial Growth Factor B Sales Market Share by Region (2018-2023)
Table 15. Global Vascular Endothelial Growth Factor B Sales by Region (2024-2034) & (K Pcs)
Table 16. Global Vascular Endothelial Growth Factor B Sales Market Share by Region (2024-2034)
Table 17. Global Vascular Endothelial Growth Factor B Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 18. Global Vascular Endothelial Growth Factor B Sales Quantity Share by Manufacturers (2018-2023)
Table 19. Global Vascular Endothelial Growth Factor B Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Vascular Endothelial Growth Factor B Revenue Share by Manufacturers (2018-2023)
Table 21. Global Vascular Endothelial Growth Factor B Price by Manufacturers 2018-2023 (USD/Pcs)
Table 22. Global Key Players of Vascular Endothelial Growth Factor B, Industry Ranking, 2021 VS 2024
Table 23. Global Vascular Endothelial Growth Factor B Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Vascular Endothelial Growth Factor B by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vascular Endothelial Growth Factor B as of 2024)
Table 25. Global Key Manufacturers of Vascular Endothelial Growth Factor B, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Vascular Endothelial Growth Factor B, Product Offered and Application
Table 27. Global Key Manufacturers of Vascular Endothelial Growth Factor B, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Vascular Endothelial Growth Factor B Sales Quantity by Type (2018-2023) & (K Pcs)
Table 30. Global Vascular Endothelial Growth Factor B Sales Quantity by Type (2024-2034) & (K Pcs)
Table 31. Global Vascular Endothelial Growth Factor B Sales Quantity Share by Type (2018-2023)
Table 32. Global Vascular Endothelial Growth Factor B Sales Quantity Share by Type (2024-2034)
Table 33. Global Vascular Endothelial Growth Factor B Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Vascular Endothelial Growth Factor B Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Vascular Endothelial Growth Factor B Revenue Share by Type (2018-2023)
Table 36. Global Vascular Endothelial Growth Factor B Revenue Share by Type (2024-2034)
Table 37. Vascular Endothelial Growth Factor B Price by Type (2018-2023) & (USD/Pcs)
Table 38. Global Vascular Endothelial Growth Factor B Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 39. Global Vascular Endothelial Growth Factor B Sales Quantity by Application (2018-2023) & (K Pcs)
Table 40. Global Vascular Endothelial Growth Factor B Sales Quantity by Application (2024-2034) & (K Pcs)
Table 41. Global Vascular Endothelial Growth Factor B Sales Quantity Share by Application (2018-2023)
Table 42. Global Vascular Endothelial Growth Factor B Sales Quantity Share by Application (2024-2034)
Table 43. Global Vascular Endothelial Growth Factor B Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Vascular Endothelial Growth Factor B Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Vascular Endothelial Growth Factor B Revenue Share by Application (2018-2023)
Table 46. Global Vascular Endothelial Growth Factor B Revenue Share by Application (2024-2034)
Table 47. Vascular Endothelial Growth Factor B Price by Application (2018-2023) & (USD/Pcs)
Table 48. Global Vascular Endothelial Growth Factor B Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 49. North America Vascular Endothelial Growth Factor B Revenue by Company (2018-2023) & (US$ Million)
Table 50. North America Vascular Endothelial Growth Factor B Sales Quantity by Company (2018-2023) & (K Pcs)
Table 51. North America Vascular Endothelial Growth Factor B Sales Quantity by Type (2018-2023) & (K Pcs)
Table 52. North America Vascular Endothelial Growth Factor B Sales Quantity by Type (2024-2034) & (K Pcs)
Table 53. North America Vascular Endothelial Growth Factor B Revenue by Type (2018-2023) & (US$ Million)
Table 54. North America Vascular Endothelial Growth Factor B Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Vascular Endothelial Growth Factor B Sales Quantity by Application (2018-2023) & (K Pcs)
Table 56. North America Vascular Endothelial Growth Factor B Sales Quantity by Application (2024-2034) & (K Pcs)
Table 57. North America Vascular Endothelial Growth Factor B Revenue by Application (2018-2023) & (US$ Million)
Table 58. North America Vascular Endothelial Growth Factor B Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Vascular Endothelial Growth Factor B Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 60. North America Vascular Endothelial Growth Factor B Revenue by Country (2018-2023) & (US$ Million)
Table 61. North America Vascular Endothelial Growth Factor B Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Vascular Endothelial Growth Factor B Sales Quantity by Country (2018-2023) & (K Pcs)
Table 63. North America Vascular Endothelial Growth Factor B Sales Quantity by Country (2024-2034) & (K Pcs)
Table 64. Europe Vascular Endothelial Growth Factor B Sales Quantity by Company (2018-2023) & (K Pcs)
Table 65. Europe Vascular Endothelial Growth Factor B Revenue by Company (2018-2023) & (US$ Million)
Table 66. Europe Vascular Endothelial Growth Factor B Sales Quantity by Type (2018-2023) & (K Pcs)
Table 67. Europe Vascular Endothelial Growth Factor B Sales Quantity by Type (2024-2034) & (K Pcs)
Table 68. Europe Vascular Endothelial Growth Factor B Revenue by Type (2018-2023) & (US$ Million)
Table 69. Europe Vascular Endothelial Growth Factor B Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Vascular Endothelial Growth Factor B Sales Quantity by Application (2018-2023) & (K Pcs)
Table 71. Europe Vascular Endothelial Growth Factor B Sales Quantity by Application (2024-2034) & (K Pcs)
Table 72. Europe Vascular Endothelial Growth Factor B Revenue by Application (2018-2023) & (US$ Million)
Table 73. Europe Vascular Endothelial Growth Factor B Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Vascular Endothelial Growth Factor B Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 75. Europe Vascular Endothelial Growth Factor B Revenue by Country (2018-2023) & (US$ Million)
Table 76. Europe Vascular Endothelial Growth Factor B Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Vascular Endothelial Growth Factor B Sales Quantity by Country (2018-2023) & (K Pcs)
Table 78. Europe Vascular Endothelial Growth Factor B Sales Quantity by Country (2024-2034) & (K Pcs)
Table 79. China Vascular Endothelial Growth Factor B Sales Quantity by Company (2018-2023) & (K Pcs)
Table 80. China Vascular Endothelial Growth Factor B Revenue by Company (2018-2023) & (US$ Million)
Table 81. China Vascular Endothelial Growth Factor B Sales Quantity by Type (2018-2023) & (K Pcs)
Table 82. China Vascular Endothelial Growth Factor B Sales Quantity by Type (2024-2034) & (K Pcs)
Table 83. China Vascular Endothelial Growth Factor B Revenue by Type (2018-2023) & (US$ Million)
Table 84. China Vascular Endothelial Growth Factor B Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Vascular Endothelial Growth Factor B Sales Quantity by Application (2018-2023) & (K Pcs)
Table 86. China Vascular Endothelial Growth Factor B Sales Quantity by Application (2024-2034) & (K Pcs)
Table 87. China Vascular Endothelial Growth Factor B Revenue by Application (2018-2023) & (US$ Million)
Table 88. China Vascular Endothelial Growth Factor B Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Vascular Endothelial Growth Factor B Sales Quantity by Company (2018-2023) & (K Pcs)
Table 90. APAC Vascular Endothelial Growth Factor B Revenue by Company (2018-2023) & (US$ Million)
Table 91. APAC Vascular Endothelial Growth Factor B Sales Quantity by Type (2018-2023) & (K Pcs)
Table 92. APAC Vascular Endothelial Growth Factor B Sales Quantity by Type (2024-2034) & (K Pcs)
Table 93. APAC Vascular Endothelial Growth Factor B Revenue by Type (2018-2023) & (US$ Million)
Table 94. APAC Vascular Endothelial Growth Factor B Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Vascular Endothelial Growth Factor B Sales Quantity by Application (2018-2023) & (K Pcs)
Table 96. APAC Vascular Endothelial Growth Factor B Sales Quantity by Application (2024-2034) & (K Pcs)
Table 97. APAC Vascular Endothelial Growth Factor B Revenue by Application (2018-2023) & (US$ Million)
Table 98. APAC Vascular Endothelial Growth Factor B Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Vascular Endothelial Growth Factor B Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 100. APAC Vascular Endothelial Growth Factor B Revenue by Region (2018-2023) & (US$ Million)
Table 101. APAC Vascular Endothelial Growth Factor B Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Vascular Endothelial Growth Factor B Sales Quantity by Region (2018-2023) & (K Pcs)
Table 103. APAC Vascular Endothelial Growth Factor B Sales Quantity by Region (2024-2034) & (K Pcs)
Table 104. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Sales Quantity by Company (2018-2023) & (K Pcs)
Table 105. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Revenue by Company (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Sales Quantity by Type (2018-2023) & (K Pcs)
Table 107. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Sales Quantity by Type (2024-2034) & (K Pcs)
Table 108. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Revenue by Type (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Sales Quantity by Application (2018-2023) & (K Pcs)
Table 111. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Sales Quantity by Application (2024-2034) & (K Pcs)
Table 112. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Revenue by Application (2018-2023) & (US$ Million)
Table 113. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Revenue by Country (2018-2023) & (US$ Million)
Table 116. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Sales Quantity by Country (2018-2023) & (K Pcs)
Table 118. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Sales Quantity by Country (2024-2034) & (K Pcs)
Table 119. Alteogen Inc Company Information
Table 120. Alteogen Inc Description and Overview
Table 121. Alteogen Inc Vascular Endothelial Growth Factor B Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 122. Alteogen Inc Vascular Endothelial Growth Factor B Product and Services
Table 123. Alteogen Inc Vascular Endothelial Growth Factor B SWOT Analysis
Table 124. Alteogen Inc Recent Developments
Table 125. CSL Ltd Company Information
Table 126. CSL Ltd Description and Overview
Table 127. CSL Ltd Vascular Endothelial Growth Factor B Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 128. CSL Ltd Vascular Endothelial Growth Factor B Product and Services
Table 129. CSL Ltd Vascular Endothelial Growth Factor B SWOT Analysis
Table 130. CSL Ltd Recent Developments
Table 131. Eli Lilly and Company Company Information
Table 132. Eli Lilly and Company Description and Overview
Table 133. Eli Lilly and Company Vascular Endothelial Growth Factor B Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 134. Eli Lilly and Company Vascular Endothelial Growth Factor B Product and Services
Table 135. Eli Lilly and Company Vascular Endothelial Growth Factor B SWOT Analysis
Table 136. Eli Lilly and Company Recent Developments
Table 137. Formycon AG Company Information
Table 138. Formycon AG Description and Overview
Table 139. Formycon AG Vascular Endothelial Growth Factor B Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 140. Formycon AG Vascular Endothelial Growth Factor B Product and Services
Table 141. Formycon AG Vascular Endothelial Growth Factor B SWOT Analysis
Table 142. Formycon AG Recent Developments
Table 143. Regeneron Pharmaceuticals Inc Company Information
Table 144. Regeneron Pharmaceuticals Inc Description and Overview
Table 145. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 146. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product and Services
Table 147. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B SWOT Analysis
Table 148. Regeneron Pharmaceuticals Inc Recent Developments
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Vascular Endothelial Growth Factor B Distributors List
Table 152. Vascular Endothelial Growth Factor B Customers List
Table 153. Vascular Endothelial Growth Factor B Market Trends
Table 154. Vascular Endothelial Growth Factor B Market Drivers
Table 155. Vascular Endothelial Growth Factor B Market Challenges
Table 156. Vascular Endothelial Growth Factor B Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Vascular Endothelial Growth Factor B Product Picture
Figure 2. Global Vascular Endothelial Growth Factor B Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Vascular Endothelial Growth Factor B Market Share by Type in 2024 & 2034
Figure 4. Aflibercept Product Picture
Figure 5. Aflibercept Biosimilar Product Picture
Figure 6. CSL-346 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Vascular Endothelial Growth Factor B Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 9. Global Vascular Endothelial Growth Factor B Market Share by Application in 2024 & 2034
Figure 10. Rectal Cancer
Figure 11. Retinal Vein Occlusion
Figure 12. Diabetic Nephropathy
Figure 13. Others
Figure 14. Vascular Endothelial Growth Factor B Report Years Considered
Figure 15. Global Vascular Endothelial Growth Factor B Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Vascular Endothelial Growth Factor B Revenue 2018-2034 (US$ Million)
Figure 17. Global Vascular Endothelial Growth Factor B Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 18. Global Vascular Endothelial Growth Factor B Sales Quantity 2018-2034 (K Pcs)
Figure 19. Global Vascular Endothelial Growth Factor B Sales Quantity Market Share by Region (2018-2023)
Figure 20. Global Vascular Endothelial Growth Factor B Sales Quantity Market Share by Region (2024-2034)
Figure 21. North America Vascular Endothelial Growth Factor B Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 22. North America Vascular Endothelial Growth Factor B Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe Vascular Endothelial Growth Factor B Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 24. Europe Vascular Endothelial Growth Factor B Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China Vascular Endothelial Growth Factor B Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 26. China Vascular Endothelial Growth Factor B Revenue YoY (2018-2034) & (US$ Million)
Figure 27. APAC Vascular Endothelial Growth Factor B Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 28. APAC Vascular Endothelial Growth Factor B Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 30. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Vascular Endothelial Growth Factor B Sales Quantity in 2024
Figure 32. The Top 10 and Top 5 Players Market Share by Vascular Endothelial Growth Factor B Revenue in 2024
Figure 33. Vascular Endothelial Growth Factor B Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 34. Global Vascular Endothelial Growth Factor B Sales Quantity Market Share by Type (2018-2034)
Figure 35. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2018-2034)
Figure 36. Global Vascular Endothelial Growth Factor B Sales Quantity Market Share by Application (2018-2034)
Figure 37. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2018-2034)
Figure 38. North America Vascular Endothelial Growth Factor B Revenue Market Share by Company in 2024
Figure 39. North America Vascular Endothelial Growth Factor B Sales Quantity Market Share by Company in 2024
Figure 40. North America Vascular Endothelial Growth Factor B Sales Quantity Market Share by Type (2018-2034)
Figure 41. North America Vascular Endothelial Growth Factor B Revenue Market Share by Type (2018-2034)
Figure 42. North America Vascular Endothelial Growth Factor B Sales Quantity Market Share by Application (2018-2034)
Figure 43. North America Vascular Endothelial Growth Factor B Revenue Market Share by Application (2018-2034)
Figure 44. North America Vascular Endothelial Growth Factor B Revenue Share by Country (2018-2034)
Figure 45. North America Vascular Endothelial Growth Factor B Sales Quantity Share by Country (2018-2034)
Figure 46. U.S. Vascular Endothelial Growth Factor B Revenue (2018-2034) & (US$ Million)
Figure 47. Canada Vascular Endothelial Growth Factor B Revenue (2018-2034) & (US$ Million)
Figure 48. Europe Vascular Endothelial Growth Factor B Sales Quantity Market Share by Company in 2024
Figure 49. Europe Vascular Endothelial Growth Factor B Revenue Market Share by Company in 2024
Figure 50. Europe Vascular Endothelial Growth Factor B Sales Quantity Market Share by Type (2018-2034)
Figure 51. Europe Vascular Endothelial Growth Factor B Revenue Market Share by Type (2018-2034)
Figure 52. Europe Vascular Endothelial Growth Factor B Sales Quantity Market Share by Application (2018-2034)
Figure 53. Europe Vascular Endothelial Growth Factor B Revenue Market Share by Application (2018-2034)
Figure 54. Europe Vascular Endothelial Growth Factor B Revenue Share by Country (2018-2034)
Figure 55. Europe Vascular Endothelial Growth Factor B Sales Quantity Share by Country (2018-2034)
Figure 56. Germany Vascular Endothelial Growth Factor B Revenue (2018-2034) & (US$ Million)
Figure 57. France Vascular Endothelial Growth Factor B Revenue (2018-2034) & (US$ Million)
Figure 58. U.K. Vascular Endothelial Growth Factor B Revenue (2018-2034) & (US$ Million)
Figure 59. Italy Vascular Endothelial Growth Factor B Revenue (2018-2034) & (US$ Million)
Figure 60. Russia Vascular Endothelial Growth Factor B Revenue (2018-2034) & (US$ Million)
Figure 61. China Vascular Endothelial Growth Factor B Sales Quantity Market Share by Company in 2024
Figure 62. China Vascular Endothelial Growth Factor B Revenue Market Share by Company in 2024
Figure 63. China Vascular Endothelial Growth Factor B Sales Quantity Market Share by Type (2018-2034)
Figure 64. China Vascular Endothelial Growth Factor B Revenue Market Share by Type (2018-2034)
Figure 65. China Vascular Endothelial Growth Factor B Sales Quantity Market Share by Application (2018-2034)
Figure 66. China Vascular Endothelial Growth Factor B Revenue Market Share by Application (2018-2034)
Figure 67. APAC Vascular Endothelial Growth Factor B Sales Quantity Market Share by Company in 2024
Figure 68. APAC Vascular Endothelial Growth Factor B Revenue Market Share by Company in 2024
Figure 69. APAC Vascular Endothelial Growth Factor B Sales Quantity Market Share by Type (2018-2034)
Figure 70. APAC Vascular Endothelial Growth Factor B Revenue Market Share by Type (2018-2034)
Figure 71. APAC Vascular Endothelial Growth Factor B Sales Quantity Market Share by Application (2018-2034)
Figure 72. APAC Vascular Endothelial Growth Factor B Revenue Market Share by Application (2018-2034)
Figure 73. APAC Vascular Endothelial Growth Factor B Revenue Share by Region (2018-2034)
Figure 74. APAC Vascular Endothelial Growth Factor B Sales Quantity Share by Region (2018-2034)
Figure 75. Japan Vascular Endothelial Growth Factor B Revenue (2018-2034) & (US$ Million)
Figure 76. South Korea Vascular Endothelial Growth Factor B Revenue (2018-2034) & (US$ Million)
Figure 77. China Taiwan Vascular Endothelial Growth Factor B Revenue (2018-2034) & (US$ Million)
Figure 78. Southeast Asia Vascular Endothelial Growth Factor B Revenue (2018-2034) & (US$ Million)
Figure 79. India Vascular Endothelial Growth Factor B Revenue (2018-2034) & (US$ Million)
Figure 80. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Sales Quantity Market Share by Company in 2024
Figure 81. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Revenue Market Share by Company in 2024
Figure 82. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Sales Quantity Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Revenue Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Sales Quantity Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Revenue Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Sales Quantity Share by Country (2018-2034)
Figure 87. Middle East, Africa and Latin America Vascular Endothelial Growth Factor B Revenue Share by Country (2018-2034)
Figure 88. Brazil Vascular Endothelial Growth Factor B Revenue (2018-2034) & (US$ Million)
Figure 89. Mexico Vascular Endothelial Growth Factor B Revenue (2018-2034) & (US$ Million)
Figure 90. Turkey Vascular Endothelial Growth Factor B Revenue (2018-2034) & (US$ Million)
Figure 91. Israel Vascular Endothelial Growth Factor B Revenue (2018-2034) & (US$ Million)
Figure 92. GCC Countries Vascular Endothelial Growth Factor B Revenue (2018-2034) & (US$ Million)
Figure 93. Vascular Endothelial Growth Factor B Value Chain
Figure 94. Vascular Endothelial Growth Factor B Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed